Depression and Hypothalamic-Pituitary-Adrenal Activation: A Quantitative Summary of Four Decades of Research
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Objectives To summarize quantitatively the literature comparing hypothalamic-pituitary-adrenal (HPA) axis function between depressed and nondepressed individuals and to describe the important sources of variability in this literature. These sources include methodological differences between studies, as well as demographic or clinical differences between depressed samples. Methods The current study used meta-analytic techniques to compare 671 effect sizes (cortisol, adrenocorticotropic hormone, or corticotropin-releasing hormone) across 361 studies, including 18,454 individuals. Results Although depressed individuals tended to display increased cortisol (d = 0.60; 95% confidence interval [CI], 0.54-0.66) and adrenocorticotropic hormone levels (d = 0.28; 95% CI, 0.16-0.41), they did not display elevations in corticotropin-releasing hormone (d = 0.02; 95% CI, -0.47-0.51). The magnitude of the cortisol effect was reduced by almost half (d = 0.33; 95% CI, 0.21-0.45) when analyses were limited to studies that met minimal methodological standards. Gender did not significantly modify any HPA outcome. Studies that included older hospitalized individuals reported significantly greater cortisol differences between depressed and nondepressed groups compared with studies with younger outpatient samples. Important cortisol differences also emerged for atypical, endogenous, melancholic, and psychotic forms of depression. Conclusions The current study suggests that the degree of HPA hyperact…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additional studies on the pathological mechanism of depression have suggested that the HPA axis is hyperactive in MDD patients and that sensitivity to negative feedback is decreased. 15”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [15]
In the citing paper
“Chronic hyperactivation of the stress system is related to hypersecretion of corticotropin releasing hormone and arginine-vasopressin (CRH, AVP) by the hypothalamus and ACTH hypersecretion by the pituitary (76), resulting in higher circulating cortisol levels due also to an “insensitive” negative glucocorticoid (GC) feedback of the HPA axis loop (77).”
From Developmental Trajectories of Early Life Stress and Trauma: A Narrative Review on Neurobiological Aspects Beyond Stress System Dysregulation (2019) · cites this paper as [77]
In the citing paper
“A further metaanalysis of 18,374 adult individuals found higher cortisol in MDD when measured continuously throughout the day, with morning times revealing the least difference between the groups.”
From Childhood Trauma, the HPA Axis and Psychiatric Illnesses: A Targeted Literature Synthesis (2022) · cites this paper as [158]
In the citing paper
“Post DST, higher cortisol and reduced ACTH were found with MDD compared to non-depressed in a metanalysis of 1,639 adults (158).”
From Childhood Trauma, the HPA Axis and Psychiatric Illnesses: A Targeted Literature Synthesis (2022) · cites this paper as [158]
In the citing paper
“ACTH was also higher overall in MDD patients; however, there was no difference between control and depressed patients at any one time of day (158).”
From Childhood Trauma, the HPA Axis and Psychiatric Illnesses: A Targeted Literature Synthesis (2022) · cites this paper as [158]
14 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences (2nd ed.).
Lachenbruch, P. A., & Cohen, J. (1989) · Journal of the American Statistical Association · doi:10.2307/2290095 · Cited by 37,395
Dickerson, S. S., & Kemeny, M. E. (2004) · Psychological Bulletin · doi:10.1037/0033-2909.130.3.355 · Cited by 5,881
Statistical Methods for Meta-Analysis.
Freeman, P. R., Hedges, L. V., & Olkin, I. (1986) · Biometrics · doi:10.2307/2531069 · Cited by 4,784
Fixed-and random-effects models in meta-analysis.
Hedges, L. V., & Vevea, J. L. (1998) · Psychological Methods · doi:10.1037/1082-989x.3.4.486 · Cited by 2,977
Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766
Miller, G. E., Chen, E., & Zhou, E. S. (2007) · Psychological Bulletin · doi:10.1037/0033-2909.133.1.25 · Cited by 2,467 · cited 1×
“This is important because it is these processes, rather than increased cortisol levels, that are more closely linked to disease outcomes (18,35).”
BackgroundSelf-citationThe HPA axis in major depression: classical theories and new developments
Pariante, C. M., & Lightman, S. L. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.06.006 · Cited by 2,009
Cortisol levels during human aging predict hippocampal atrophy and memory deficits
Lupien, S. J., de Leon, M., de Santi, S., Convit, A., Tarshish, C., Nair, N. P. V., Thakur, M., McEwen, B. S., Hauger, R. L., & Meaney, M. J. (1998) · Nature Neuroscience · doi:10.1038/271 · Cited by 1,653 · cited 1×
“These individuals are, therefore, more likely to be at risk for conditions where excessive cortisol is thought to play a pathogenic role, such as Type II diabetes, osteoporosis, or dementia (33,34).”
BackgroundGold, P. W., & Chrousos, G. P. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001032 · Cited by 1,274
Depression and cortisol responses to psychological stress: A meta-analysis
Burke, H. M., Davis, M. C., Otte, C., & Mohr, D. C. (2005) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.02.010 · Cited by 1,194
Cited by
Items 401–500 of 1,305
Xu, Z., Wu, X., Xiao, C., Zhang, W., Yan, P., Yang, C., Zhang, L., Cui, H., Tang, M., Wang, Y., et al. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.12.028 · Cited by 40
Virtual Reality Therapy for Depression and Mood in Long-Term Care Facilities
Zhai, K., Dilawar, A., Yousef, M. S., Holroyd, S., El-Hammali, H., & Abdelmonem, M. (2021) · Geriatrics · doi:10.3390/geriatrics6020058 · Cited by 39
“However, in mild, chronic, or atypical depression, variability exists in the responsiveness of the HPA axis to stressors [30-33].”
BackgroundWalther, A., Rice, T., Kufert, Y., & Ehlert, U. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00206 · Cited by 39
“HPA axis disturbances have been linked to the development and maintenance of depression (27).”
BackgroundThe Role of Natural Products in Treatment of Depressive Disorder
Noori, T., Sureda, A., Sobarzo-Sánchez, E., & Shirooie, S. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220103140834 · Cited by 39
Zahn, D., Petrak, F., Franke, L., Hägele, A.-K., Juckel, G., Lederbogen, F., Neubauer, H. P., Norra, C., Uhl, I., & Herpertz, S. (2015) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000145 · Cited by 38
“patient characteristics might also influence the observed association: These include measurement of basal cortisol levels versus cortisol response in dexamethasone suppression tests, bodily fluid (saliva, blood, or urine), single versus multiple cortisol assessments, age, hospitalization status, or subtypes of depress…”
BackgroundThe brain derived neurotrophic factor and influences of stress in depression.
Kimpton, J. (2012) · PubMed · Cited by 40
Sarubin, N., Hilbert, S., Naumann, F., Zill, P., Wimmer, A.-M., Nothdurfter, C., Rupprecht, R., Baghai, T. C., Bühner, M., & Schüle, C. (2016) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-016-0722-5 · Cited by 39
Chen, Z., Zhao, S., Tian, S., Yan, R., Wang, H., Wang, X., Zhu, R., Xia, Y. X., Yao, Z., & Lü, Q. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.10.087 · Cited by 39
Childhood trauma and HPA axis functionality in offspring of bipolar parents
Schreuder, M. M., Vinkers, C. H., Mesman, E., Claes, S., Nolen, W. A., & Hillegers, M. H. J. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.09.017 · Cited by 37
Du, X., Pang, T. Y., Mo, C., Renoir, T., Wright, D. J., & Hannan, A. J. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.09.009 · Cited by 37
“Its hyperactivity is themost consistently found biological abnormality in clinical depression (Lok et al., 2012; Pariante and Lightman, 2008; Stetler and Miller, 2011).”
Blood-based immune-endocrine biomarkers of treatment response in depression
Chan, M. K., Cooper, J. D., Bot, M., Birkenhager, T. K., Bergink, V., Drexhage, H. A., Steiner, J., Rothermundt, M., Penninx, B. W. J. H., & Bahn, S. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.08.020 · Cited by 36
Stapelberg, N. J. C., Neumann, D. L., Shum, D., & Headrick, J. P. (2018) · Physiology & Behavior · doi:10.1016/j.physbeh.2018.10.014 · Cited by 37
Du, X., Pang, T. Y., & Hannan, A. J. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00081 · Cited by 38
Neurobiological Underpinnings of Hyperarousal in Depression: A Comprehensive Review
Xie, M., Huang, Y., Cai, W., Zhang, B., Huang, H. D., Li, Q., Qin, P., & Han, J. (2024) · Brain Sciences · doi:10.3390/brainsci14010050 · Cited by 38
“For now, altered activities of several arousal neural correlates have been identified in depression, such as the hypothalamic–pituitary–adrenal (HPA) axis [22,23] and locus coeruleus (LC) [3,24].”
BackgroundResultInfluentialEmotional suppression in chronic fatigue syndrome: Experimental study.
Rimes, K. A., Ashcroft, J., Bryan, L., & Chalder, T. (2016) · Health Psychology · doi:10.1037/hea0000341 · Cited by 38
Antipsychotics as antidepressants: what is the mechanism?
Šagud, M., Mihaljević-Peleš, A., Begić, D., Vuksan‐Ćusa, B., Kramarić, M., Živković, M., & Jakovljević, M. (2011) · PubMed · Cited by 37
Puustinen, T., Tervonen, J., Avellan, C., Jyrkkänen, H.-K., Paterno, J. J., Hartikainen, P. H., Vanhanen, U., Leinonen, V., Lehto, S. M., Elomaa, A.-P., et al. (2019) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2019.105527 · Cited by 36
“For example, neuroendocrine studies have consistently demonstrated HPA axis dysfunction in major depression [32].”
BackgroundGlucagon-like peptide-2 but not imipramine exhibits antidepressant-like effects in ACTH-treated mice
Iwai, T., Ohnuki, T., Sasaki‐Hamada, S., Saitoh, A., Sugiyama, A., & Oka, J. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.01.010 · Cited by 36
Baumeister, D., Lightman, S. L., & Pariante, C. M. (2016) · Psychopathology Review · doi:10.5127/pr.034413 · Cited by 37
“…associated with increased cortisol and ACTH but not CRH levels, individual subtypes differed: atypical depression was associated with a third of an SD lower, melancholic depression a quarter of an SD higher, and psychotic depression nearly half an SD higher cortisol levels (Stetler & Miller, 2011).”
BackgroundFamilial aggregation and heritability of the melancholic and atypical subtypes of depression
Lamers, F., Cui, L., Hickie, I. B., Roca, C., Machado‐Vieira, R., Zarate, C. A., & Merikangas, K. R. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.06.040 · Cited by 36
Wang, Z., Dang, J., Zhang, X., Moore, J. B., & Li, R. (2020) · Quality of Life Research · doi:10.1007/s11136-020-02620-4 · Cited by 37
Lee, J.-H., Kim, J. Y., & Jahng, J. W. (2014) · Endocrinology and Metabolism · doi:10.3803/enm.2014.29.2.169 · Cited by 37
Towards a Personalized Treatment in Depression: Endocannabinoids, Inflammation and Stress Response
Zajkowska, Z., Englund, A., & Zunszain, P. A. (2014) · Pharmacogenomics · doi:10.2217/pgs.14.40 · Cited by 37
Menke, A., Arloth, J., Best, J., Namendorf, C., Gerlach, T., Czamara, D., Lucae, S., Dunlop, B. W., Crowe, T. M., Garlow, S. J., et al. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.04.003 · Cited by 35
Zhang, B., Hong-sheng, C., Hu, K., Yu, X. L., Li, L., & Xu, X. (2019) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-019-3051-5 · Cited by 35
“Therefore, it is important to elucidate other possible mechanisms that may cause depression, and develop drugs to inhibit these pathways with fewer adverse reactions.((3,4))”
BackgroundAraç, S., & Dönmezdil, S. (2020) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.2020.0272.r3.21072020 · Cited by 35
Wang, J., Sun, L., You, J., Peng, H., Yan, H., Wang, J., Sun, F., Cui, M., Wang, S., Zhang, Z., et al. (2023) · EMBO Reports · doi:10.15252/embr.202357176 · Cited by 35
“…autonomic dysfunction, poor dietary habits, environmental, economic and sociocultural risk factors, physical inactivity and sedentary lifestyle (Gangwisch, 2009; Stetler & Miller, 2011; Courtet & Oli (cid:1) e, 2012; Holt et al , 2014; Mahar et al , 2014; Westfall et al , 2021; Wu et al , 2021).”
Human, L. J., Whillans, A. V., Hoppmann, C. A., Klumb, P. L., Dickerson, S. S., & Dunn, E. W. (2015) · Emotion · doi:10.1037/emo0000071 · Cited by 35
“Although levels of cortisol are less consistently linked to health and well-being (both high and low levels can be problematic), levels of cortisol tend to be higher in people with depression (Stetler & Miller, 2011).”
BackgroundCarnevali, L., Statello, R., Vacondio, F., Ferlenghi, F., Spadoni, G., Rivara, S., Mor, M., & Sgoifo, A. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.12.119 · Cited by 35
GILZ: Glitzing up our understanding of the glucocorticoid receptor in psychopathology
Thiagarajah, A. S., Eades, L. E., Thomas, P. R., Guymer, E. K., Morand, E. F., Clarke, D. M., & Leech, M. T. (2014) · Brain Research · doi:10.1016/j.brainres.2014.06.008 · Cited by 36
Major Depression as a Neuroprogressive Prelude to Dementia: What Is the Evidence?
Leonard, B. E. (2017) · Modern trends in psychiatry · doi:10.1159/000470807 · Cited by 35
Exogenous Glucocorticoids Decrease Subgenual Cingulate Activity Evoked by Sadness
Sudheimer, K. D., Abelson, J. L., Taylor, S. F., Martis, B., Welsh, R. C., Warner, C., Samet, M., Manduzzi, A., & Liberzon, I. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.249 · Cited by 35
“Low-arousal symptoms are commonly found in melancholic depression subtypes, which also have amongt the most reliable HPA dysregulation (Stetler and Miller, 2011).”
BackgroundFunke, R., Eichler, A., Distler, J., Golub, Y., Kratz, O., & Moll, G. H. (2016) · Stress and Health · doi:10.1002/smi.2736 · Cited by 36
“If the stress response is inadequate or excessive and prolonged, hypersecretion of corticosteroids increases the risk for depression (Stetler & Miller, 2011).”
BackgroundKlimes‐Dougan, B., Papke, V., Carosella, K. A., Wiglesworth, A., Mirza, S. A., Espensen-Sturges, T. D., & Meester, C. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104528 · Cited by 35
Vasopressin V1B receptor antagonists as potential antidepressants
Chaki, S. (2021) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyab013 · Cited by 34
“…of the hypothalamus-pituitary-adrenal (HPA) axis is generally acknowledged to occur in a subset of MDD patients (Dinan and Scott, 2005; Stetler and Miller, 2011), and patients with treatment-resistant depression or severe depression tend to show HPA axis dysfunction (Juruena et al., 2009;…”
BackgroundDing, Y., Wei, Z., Yan, H., & Guo, W. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.732157 · Cited by 34
“Subsequent studies further observed blunted cortisol circadian rhythms (Stetler and Miller, 2011), excessive HPA axis activity (Amsterdam et al., 1987; Ising et al., 2007; Menke et al., 2016), and impaired negative feedback in MDD (Arborelius et al., 1999; Dwyer et al., 2020).”
BackgroundAssociations between DSM-IV mental disorders and subsequent self-reported diagnosis of cancer
O’Neill, S. M., Posada‐Villa, J., Medina‐Mora, M. E., Al-Hamzawi, A. O., Piazza, M., Tachimori, H., Hu, C., Lim, C. C. W., Bruffaerts, R., Lépine, J., et al. (2014) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2013.12.012 · Cited by 34
Mocking, R. J. T., Figueroa, C. A., Rive, M. M., Geugies, H., Servaas, M. N., Assies, J., Koeter, M. W. J., Vaz, F. M., Wichers, M., van Straalen, J. P., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-009510 · Cited by 31
“89 94 Aberrations in the default-mode network (ie, failure to deactivate default mode network (DMN) regions) 95 during tasks as well as DMN hyper-connectivity 96 during rest have been observed in MDD. DMN aberrations have been associated with emotional-cognitive disturbances and increased negative self-focus, such as…”
BackgroundInfluentialMezuk, B. R., Heh, V., Prom‐Wormley, E. C., Kendler, K. S., & Pedersen, N. L. (2015) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000182 · Cited by 34
“, cigarette smoking, diets high in fats and sugar, and alcohol use) that in turn increase risk of T2DM (and also potentially MD) (37,38).”
BackgroundCui, M., Kimura, T., Ikehara, S., Dong, J.-Y., Ueda, K., Kawanishi, Y., Kimura, T., & Iso, H. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.11.145 · Cited by 34
Li, N., Song, Q., Su, W., Guo, X., Wang, H., Liang, Q., Liang, M., Qu, G., Ding, X., Zhou, X., et al. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-20841-7 · Cited by 34
Nowacki, J., Wingenfeld, K., Kaczmarczyk, M., Chae, W. R., Salchow, P., Abu-Tir, I., Piber, D., Hellmann‐Regen, J., & Otte, C. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0789-7 · Cited by 35
“For systolic blood pressure, we found a main effect of time (F(5,1150)= 43.”
BackgroundLUPIEN, S. J., Leclaire, S., Majeur, D., Raymond, C., Baptiste, F. J., & Giguère, C. (2022) · Neurobiology of Stress · doi:10.1016/j.ynstr.2022.100454 · Cited by 34
“2 glucocorticoids are observed in depressed compared to non-depressed individuals (Stetler and Miller 2011).”
The Unique Impact of Late-Life Bereavement and Prolonged Grief on Diurnal Cortisol
Holland, J. M., Rozalski, V., Thompson, K. L., Tiongson, R. J., Schatzberg, A. F., O'Hara, R. M., & Gallagher-Thompson, D. E. (2013) · The Journals of Gerontology Series B · doi:10.1093/geronb/gbt051 · Cited by 34
Carnevali, L., Vacondio, F., Rossi, S., Callegari, S., Macchi, E., Spadoni, G., Bedini, A., Rivara, S., Mor, M., & Sgoifo, A. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.07.015 · Cited by 34
Presynaptic Plasticity as a Hallmark of Rat Stress Susceptibility and Antidepressant Response
Nieto-Gonzalez, J. L., Holm, M. M., Vardya, I., Christensen, T., Wiborg, O., & Jensen, K. (2015) · PLOS ONE · doi:10.1371/journal.pone.0119993 · Cited by 35
“In humans, there is a tendency to increased levels of cortisol and HPA hyperactivity in depressed patients [35].”
BackgroundCheng, T., Dimitrov, S., Pruitt, C., & Hong, S. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.01.008 · Cited by 33
“Increased levels of cortisol, corticotropin releasing hormone, and the size and activity of pituitary and adrenal glands are often, although not always, found in major depression (Pace and Miller, 2009; Stetler and Miller, 2011; Zunszain et al., 2011).”
BackgroundUlbricht, C. M., Rothschild, A. J., & Lapane, K. L. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.08.039 · Cited by 33
Garcia-Leal, C., de Rezende, M. G., Zuelli, F. M. D. G. C., de Castro, M., & Del‐Ben, C. M. (2017) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2017.1347500 · Cited by 34
“A review about the HPA functioning in depression suggested that the use of several measures during the day, over several days, which allows to analyze the area under the curve and slope values of hormone levels, would produce more consistent results [21].”
ResultSleep quality and depressive symptoms after prostate cancer: The mechanistic role of cortisol.
Hoyt, M. A., Bower, J. E., Irwin, M. R., Weierich, M. R., & Stanton, A. L. (2016) · Behavioral Neuroscience · doi:10.1037/bne0000107 · Cited by 33
Why Does Psychotherapy Work and for Whom? Hormonal Answers
Fischer, S., & Zilcha‐Mano, S. (2022) · Biomedicines · doi:10.3390/biomedicines10061361 · Cited by 33
“Individuals with major depressive disorder are typically characterised by enhanced basal cortisol concentrations when compared to healthy controls [20].”
BackgroundHeterogeneity in major depressive disorder: The need for biomarker-based personalized treatments
Suseelan, S., & Pinna, G. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2022.09.001 · Cited by 33
Fráguas, R., Terroni, L. D. M. N., Amaro, E., Iosifescu, D. V., Mattos, P. F., Yamamoto, F. I., Tinone, G., Conforto, A. B., Sobreiro, M. D. F. M., Guajardo, V. D., et al. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s73722 · Cited by 33
“Corticotrophin hormone assessment and several cortisol measurements could give a more detailed and reliable appraisal of HPA function.(34) The cross-sectional design of our study restricts conclusions about direction of causality in the association between increased cortisol levels and anhedonia.”
Komori, T. (2015) · Mental Illness · doi:10.4081/mi.2015.5647 · Cited by 33
Physiological stress markers, mental health and objective physical function
Milligen, B. A. L.-V., Lamers, F., Smit, J. H., & Penninx, B. W. J. H. (2020) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2020.109996 · Cited by 32
Muscatello, R. A., Andujar, J. D., Taylor, J. L., & Corbett, B. A. (2020) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-020-04516-1 · Cited by 33
Heinzmann, J.-M., Kloiber, S. M., Mattos, G. E., Bielohuby, M., Schmidt, M. V., Palme, R., Holsboer, F., Uhr, M., Ising, M., & Touma, C. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.07.008 · Cited by 32
Rengasamy, M. L., Marsland, A. L., Spada, M. L., Hsiung, K. S., Kovats, T., & Price, R. B. (2021) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2021.100177 · Cited by 32
“In depression, numerous studies demonstrate abnormal dexamethasone cortisol response (e.g. decreased suppression of cortisol after administration of dexamethasone) or hypercortisolemia (Stetler and Miller, 2011).”
Holt-Gosselin, B., Tozzi, L., Ramirez, C. A., Gotlib, I. H., & Williams, L. M. (2021) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2021.06.007 · Cited by 32
MicroRNAs in Major Depressive Disorder
Fries, G. R., Zhang, W., Benevenuto, D., & Quevedo, J. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-05542-4_9 · Cited by 31
Incorporating cortisol into the NAPLS2 individualized risk calculator for prediction of psychosis
Worthington, M., Walker, E. F., Addington, J., Bearden, C. E., Cadenhead, K. S., Cornblatt, B. A., Mathalon, D. H., McGlashan, T. H., Perkins, D. O., Seidman, L. J., et al. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.09.022 · Cited by 31
Walther, A., Kirschbaum, C., Wehrli, S., Rothe, N., Penz, M. S., Wekenborg, M., & Gao, W. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110658 · Cited by 31
Gupta, D., Radhakrishnan, M., Kurhe, Y., Devadoss, T., Prabhakar, V., & Kanade, P. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.89 · Cited by 31
Interleukin 1B gene (IL1B) variation and internalizing symptoms in maltreated preschoolers
Ridout, K. K., Parade, S. H., Seifer, R., Price, L. H., Gelernter, J., Feliz, P., & Tyrka, A. R. (2014) · Development and Psychopathology · doi:10.1017/s0954579414001023 · Cited by 28
“…well established in association with early stress exposure and internalizing symptoms and disorders (Carpenter et al., 2007; Carpenter, Shattuck, Tyrka, Geracioti, & Price, 2011; Hartman, Hermanns, de Jong, & Ormel, 2013; Lupien et al., 2009; Morris, Compas, & Garber, 2012; Stetler & Miller, 2011).”
So, H., Chau, C. K., Lau, A., Wong, S., & Zhao, K. (2018) · Psychological Medicine · doi:10.1017/s0033291718003641 · Cited by 31
“A number of studies (Gold and Chrousos, 2002; Stetler and Miller, 2011; Lamers et al., 2013) have shown that hyperactivity of the hypothalamic–pituitary axis is an important feature of melancholic depression.”
BackgroundGlucocorticoid-Mediated Developmental Programming of Vertebrate Stress Responsivity
Gans, I. M., & Coffman, J. A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.812195 · Cited by 31
Kanes, S., Dennie, L., & Perera, P. (2023) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s402831 · Cited by 31
“studies, which may be due to the unique pathological characteristics of different neuropsychiatric diseases and the heterogeneity and syndromal nature of many illnesses, as well as the methods employed to study them.(61,180,181) Regarding V1b receptors specifically, their activity and the potential efficacy of antagon…”
InfluentialShukkoor, M. S. A., Baharuldin, M. T. H., Jais, A. M. M., Moklas, M. A. M., & Fakurazi, S. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/2986090 · Cited by 31
Nair, B. B., Khant Aung, Z., Porteous, R., Prescott, M., Glendining, K. A., Jenkins, D. E., Augustine, R. A., Silva, M. S. B., Yip, S. H., Bouwer, G. T., et al. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.12972 · Cited by 30
Psychobiological impact of ethnic discrimination in Turkish immigrants living in Germany
Fischer, S., Nater, U. M., Strahler, J., Skoluda, N., Dieterich, L., Oezcan, O., & Mewes, R. (2017) · Stress · doi:10.1080/10253890.2017.1296430 · Cited by 30
“Since altered cortisol concentrations are common in depressive disorders (Stetler & Miller, 2011), the German version of the Patient Health Questionnaire mood scale (PHQ-9; L€owe et al., 2002) was used to exclude participants currently suffering from major depression.”
MethodFigueiredo, P., Ramião, E., Azeredo, A., Moreira, D. S., Barroso, R., & Barbosa, F. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.113088 · Cited by 30
Bi, Y., Ren, D., Guo, Z., Ma, G., Xu, F., Chen, Z., An, L. K., Zhang, N., Ji, L., Yuan, F., et al. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110036 · Cited by 30
Wielaard, I., Schaakxs, R., Comijs, H. C., Stek, M. L., & Rhebergen, D. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1274829 · Cited by 30
Nabeta, H., Mizoguchi, Y., Matsushima, J., Imamura, Y., Watanabe, I., Tateishi, T., Kojima, N., Kawashima, T., Yamada, S., & Monji, A. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.02.003 · Cited by 30
“A recent meta-analysis has shown that, when compared to non-depressed controls, older adults with depression are characterized by greater HPA activation, more so than for younger adults, highlighting the relevance of cortisol as a crucial biomarker for geriatric populations (Stetler and Miller, 2011).”
BackgroundMethodMagnocellular hypothalamic system and its interaction with the hypothalamo-pituitary-adrenal axis
Sivukhina, E. V., & Jirikowski, G. F. (2016) · Steroids · doi:10.1016/j.steroids.2016.01.008 · Cited by 29
Gatta, E., Camussi, D., Auta, J., Guidotti, A., & Pandey, S. C. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108299 · Cited by 30
Gamage, E., Orr, R., Travica, N., Lane, M. M., Dissanayaka, T. D., Kim, J. H., Grosso, G., Godos, J., & Marx, W. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105225 · Cited by 29
Scott, K. M., Alonso, J., de Jonge, P., Viana, M. C., Liu, Z., O’Neill, S. M., Aguilar‐Gaxiola, S., Bruffaerts, R., Caldas‐de‐Almeida, J. M., Stein, D. J., et al. (2013) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2013.04.007 · Cited by 29
“It is conceivable, for example, that the common mechanism linking all of the emotional disorders (mood, anxiety, anger) with ulcer is related to the dysregulation of the hypothalamic– pituitary–adrenal and sympathoadrenal stress response pathways that have been associated with depression and anxiety disorders [35–37].”
Involvement of inflammatory gene expression pathways in depressed patients with hyperphagia
de Kluiver, H., Jansen, R., Milaneschi, Y., & Penninx, B. W. J. H. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0528-0 · Cited by 29
Melancholia as Predictor of Electroconvulsive Therapy Outcome in Later Life
Veltman, E. M., de Boer, A., Dols, A., van Exel, E. R., Stek, M. L., Sienaert, P. A., Bouckaert, F., van der Mast, R. C., & Rhebergen, D. (2019) · Journal of Ect · doi:10.1097/yct.0000000000000579 · Cited by 29
Can animals develop depression? An overview and assessment of ‘depression-like’ states
MacLellan, A., Fureix, C., Polanco, A., & Mason, G. J. (2021) · Behaviour · doi:10.1163/1568539x-bja10132 · Cited by 29
Lu, Q., Pan, F., Ren, L., Xiao, J., & Tao, F. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192901 · Cited by 30
Liu, J., Meng, T., Wang, C., Cheng, W., Zhang, Q., & Cheng, G. (2023) · Medicine · doi:10.1097/md.0000000000035862 · Cited by 29
Şahin, C., Dursun, S. M., Çetin, M., & Arıcıoğlu, F. (2016) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20160520092044 · Cited by 29
Green, C., Stolicyn, A., Harris, M. A., Shen, X., Romaniuk, L., Barbu, M. C., Hawkins, E. L., Wardlaw, J. M., Steele, J. D., Waiter, G. D., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01644-9 · Cited by 28
Cantave, C. Y., Langevin, S., Marin, M.-F., Brendgen, M., Lupien, S., & Ouellet-Morin, I. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.12.235 · Cited by 28
The Risk of Depression in Patients with Pemphigus: A Nationwide Cohort Study in Taiwan
Hsu, Y.-M., Fang, H.-Y., Lin, C., & Shieh, S. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17061983 · Cited by 28
“It is not known whether this is caused by differences in ethnicity [30].”
BackgroundCizza, G., Mistry, S., Nguyen, V. T., Eskandari, F., Martinez, P. E., Torvik, S., Reynolds, J. C., Gold, P. W., Sinai, N. B., Csákó, G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040894 · Cited by 28
“Alterations in the HPA axis are significant findings in biological psychiatry [50].”
BackgroundNeighborhood perceptions and allostatic load: Evidence from Midlife in the United States study
Carbone, J. T. (2019) · Health & Place · doi:10.1016/j.healthplace.2019.102263 · Cited by 28
“, 2011), preeclampsia (Hux and Roberts, 2014), osteoporosis (Stetler and Miller, 2011), multiple sclerosis (Elenkov and Chrousos, 2002), rheumatoid arthritis (Straub and Cutolo, 2001; Wilder and Elenkov, 1999), cognitive decline (Lucassen et al.”
BackgroundChronic social isolation in adaptation of HPA axis to heterotypic stress
Gądek-Michalska, A., Bugajski, A. J., Tadeusz, J., Rachwalska, P., & Bugajski, J. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.08.011 · Cited by 28
Platero, J. L., Cuerda‐Ballester, M., Sancho-Cantus, D., Benlloch, M., Cerón, J. M. C., Rubio, C. P., García-Pardo, M. P., López‐Rodriguez, M. M., & Ortí, J. E. D. L. R. (2021) · Life · doi:10.3390/life11040353 · Cited by 28
“Among these factors, the hyperactivation of the HHA axis with high levels of cortisol, related to the presence of depression in certain pathological situations, stands out [41].”
BackgroundBabicki, M., Szewczykowska, I., & Mastalerz–Migas, A. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18116101 · Cited by 28
The temporal dynamics of cortisol and affective states in depressed and non-depressed individuals
Booij, S. H., Bos, E. H., de Jonge, P., & Oldehinkel, A. J. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.03.012 · Cited by 28
Holland, J. M., Schatzberg, A. F., O’Hara, R., Marquett, R. M., & Gallagher-Thompson, D. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.07.033 · Cited by 22
“In particular, the link between hypercortisolism and depression is well established and has been documented in numerous studies over the past four decades (Holsboer, 2000; Burke et al., 2005; Neigh and Nemeroff, 2006; Pariante and Lightman, 2008; Stetler and Miller, 2011).”
BackgroundBrinsley, J., Smout, M., Girard, D., & Davison, K. (2022) · Mental health and physical activity · doi:10.1016/j.mhpa.2022.100450 · Cited by 28
Yao, T., Cui, Q., Liu, Z., Wang, C., Zhang, Q., & Wang, G. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109549 · Cited by 27
Management strategies in SSRI-associated sexual dysfunction in women at midlife
Fooladi, E., Bell, R. J., & Davis, S. R. (2012) · Climacteric · doi:10.3109/13697137.2012.658461 · Cited by 27
van Zuiden, M., Kavelaars, A., Vermetten, E. H. G. J. M., Olff, M., Geuze, E., & Heijnen, C. J. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.09.014 · Cited by 27
Patil, R., Aswar, U. M., & Vyas, N. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148494 · Cited by 27
Sex differences of salivary cortisol secretion in patients with major depression
Hinkelmann, K., Botzenhardt, J., Muhtz, C., Agorastos, A., Wiedemann, K., Kellner, M. B., & Otte, C. (2011) · Stress · doi:10.3109/10253890.2011.582200 · Cited by 27
Metadata
- Authors
- Stetler, C., & Miller, G. E.
- Affiliations
- Furman University (US)
- University of British Columbia (CA)
- Corresponding author
- Stetler, Cinnamon
- ORCID
- Miller, Gregory E.
- Venue
- Psychosomatic Medicine
- Published
- 2011-02
- Volume
- 73
- Issue
- 2
- Pages
- 114-126
- ISSN
- 0033-3174 (ISSN-L)
- OpenAlex
- W2325341530
- Semantic Scholar
- 8dd36c89fdc21f4d365839c99e1ae8e38ebdcccb
- Cited by
- 1,123
- References
- 32
- Citations by year
- 2026: 54 · 2025: 62 · 2024: 56 · 2023: 84 · 2022: 96 · 2021: 100 · 2020: 90 · 2019: 85 · 2018: 81 · 2017: 69 · 2016: 95 · 2015: 70 · 2014: 61 · 2013: 59 · 2012: 40
- FWCI
- 22.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychosomatic Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- depression, hypothalamic-pituitary-adrenal axis, cortisol, ACTH, corticotropin-releasing factor, atypical depression, endogenous depression, psychotic depression, hospitalized older adults, methodological quality, gender differences
- MeSH terms
- Adolescent, Adrenocorticotropic Hormone, Adult, Child, Corticotropin-Releasing Hormone, Depressive Disorder, Female, Humans, Hydrocortisone, Hypothalamo-Hypophyseal System, Male, Middle Aged, Pituitary-Adrenal System, Research, Bibliometrics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.